2017
DOI: 10.1007/s11325-017-1579-1
|View full text |Cite
|
Sign up to set email alerts
|

Sleep disorders and health-related quality of life in patients with interstitial lung disease

Abstract: In this sample of patients with IPF and sarcoidosis, obstructive sleep apnea is common at least in a mild degree of severity. The SF-36 questionnaire may be a useful tool for the evaluation of the quality of life in these patients.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
22
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 40 publications
(26 citation statements)
references
References 24 publications
4
22
0
Order By: Relevance
“…HRQoL was measured at baseline using the Short Form Health Survey (SF-36). The aim of SF-36 is to characterize and understand the relationship between the selected baseline clinical covariates, the physical component score (PCS), and the mental component score (MCS) [25]. This questionnaire is a validated instrument for assessing HRQoL and has been applied to a variety of chronic medical conditions, including IPF [7].…”
Section: Data Collectionmentioning
confidence: 99%
“…HRQoL was measured at baseline using the Short Form Health Survey (SF-36). The aim of SF-36 is to characterize and understand the relationship between the selected baseline clinical covariates, the physical component score (PCS), and the mental component score (MCS) [25]. This questionnaire is a validated instrument for assessing HRQoL and has been applied to a variety of chronic medical conditions, including IPF [7].…”
Section: Data Collectionmentioning
confidence: 99%
“…light/dark cycles, eating/fasting activity) [ 2 ]. However, the temporal entrainment by the environment enables the physiological processes to be optimized with respect to daily changes and improves survival [ 3 5 ].…”
Section: Introductionmentioning
confidence: 99%
“…Interestingly, c-PAP therapy led to a normalization of eNO parameters, suggesting its potential role as a biomarker of compliance and response to therapy [ 97 , 98 ]. Although a significant percentage of ILD patients suffer from OSA [ 99 , 100 ], no data are currently available about eNO parameters in this setting. Despite lack of evidence, a significant influence of OSA on eNO parameters is likely and, therefore, quality of sleep should be assessed in ILD patients, considering also its negative prognostic impact [ 101 ].…”
Section: Comorbidities/complications Of Ilds: a Pitfall For Eno Anmentioning
confidence: 99%